Aired Last month 0:56
Newsradio 950 WWJ 24 Hour News | Newsradio 950 WWJ
Wall street Update: Biogen shares plunge, Nike stock down 2%
From the news
Aired Last month 26:53
Biogen Was The Train Wreck Everyone Saw Coming: Nisen (Podcast)
Max Nisen, Bloomberg Opinion health care columnist, on Biogen plunging after the company and its partner Eisai announced it was halting their Alzheimer drug trial. Gad Levanon, Chief Economist: North America at the Conference Board, on the February Leading Index and the Fed decision. Bill Zox, CIO of Fixed income at Diamond Hill Capital Management, to discuss the Fed, the fixed income markets and where he sees opportunities. Chen Grazutis, Apparel and Footwear Analyst from Bloomberg Intelligence, on the valuation for Levi Strauss IPO. Hosted by Lisa Abramowicz and Paul Sweeney.
P&L With Pimm Fox and Lisa Abramowicz
Aired Last month 17:50
The Lollipop War Has Begun
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll. Get $50 off your first job post at www.LinkedIn.com/Fool.
Aired Last month 1:42
Midday Brief for Thursday, March 21st
New Zealand to impose gun ban after massacre. A Boeing executive defends the design and production processes of the 737 MAX jet. Biogen says it'll end two major trials for an Alzheimer's treatment. Charlie Turner reports.Learn more about your ad choices. Visit megaphone.fm/adchoices
WSJ Minute Briefing